Camlin Fine Sciences has informed that the Company has allotted 26625 equity shares of face value of Re 1 each in accordance with the terms of ESOP 2018, on 21st December, 2021. Consequent to the said allotment the paid up share capital of the Company has gone up to 127628371 equity shares of face value of Re 1 each aggregating to Rs 12,76,28,371.
The above information is a part of company’s filings submitted to BSE.